C&R Research Inc. (KOSDAQ:359090)
South Korea · Delayed Price · Currency is KRW 2,245.00
+10.00 (0.45%)
At close: Oct 23, 2026
C&R Research Market Cap
C&R Research has a market cap or net worth of 25.8 billion as of October 23, 2026. It is the 37,078th most valuable company in the world and the 2,261st biggest in South Korea. Its market cap has decreased by 52.49% in one year.
Market Cap
25.80B
Enterprise Value
23.04B
Revenue
63.55B
Global Rank
Country Rank
#2,261 South Korea
PE Ratio
15.60
ChartMarket Cap Chart
Since December 9, 2021, C&R Research's market cap has increased from 19.05B to 25.80B, an increase of 35.44%. That is a compound annual growth rate of 6.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 25.80B | -50.12% |
| Dec 30, 2025 | 51.72B | -21.53% |
| Dec 30, 2024 | 65.91B | 0.98% |
| Dec 28, 2023 | 65.27B | 5.47% |
| Dec 29, 2022 | 61.89B | -42.89% |
| Dec 30, 2021 | 108.38B | 468.92% |
| Dec 9, 2021 | 19.05B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Penetrium Bioscience | 313.25B |
| DreamCIS | 104.18B |
| HLB bioStep | 103.40B |
| P&K Skin Research Center | 47.65B |
| Kolmar BioTech | 35.59B |
| DT&CRO CO. | 29.79B |
| SLS BIO | 26.89B |
| Curachem | 12.65B |